A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections

Despite recent studies of immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), little is known about how the immune response against SARS-CoV-2 differs from other respiratory infections. We compare the immune signature from hospitalized SARS-CoV-2–infected patients to patients h...

Descripción completa

Detalles Bibliográficos
Autores principales: Vick, Sarah C., Frutoso, Marie, Mair, Florian, Konecny, Andrew J., Greene, Evan, Wolf, Caitlin R., Logue, Jennifer K., Franko, Nicholas M., Boonyaratanakornkit, Jim, Gottardo, Raphael, Schiffer, Joshua T., Chu, Helen Y., Prlic, Martin, Lund, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580318/
https://www.ncbi.nlm.nih.gov/pubmed/34757794
http://dx.doi.org/10.1126/sciadv.abj0274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580318/
https://www.ncbi.nlm.nih.gov/pubmed/34757794
http://dx.doi.org/10.1126/sciadv.abj0274

Ejemplares similares